Anunoby's Hamstring Timeline Accelerates ECF Preparation Window

OG Anunoby returned to full practice participation Saturday, signaling a speedier bounce-back from the right hamstring injury he suffered in Game 2 of the Knicks' sweep over Philadelphia. The injury initially triggered concern given its timing and Anunoby's defensive anchoring role, but his own assessment—that the strain feels materially lighter than the left hamstring tear that sidelined him for four games in the 2024 playoffs—carries real weight. Anunoby has now been a full participant for two consecutive days, and the Knicks have granted him maximum recovery runway thanks to Cleveland and Detroit forcing a Game 7 on Sunday.

The calendar worked in New York's favor. Tuesday's Game 1 of the ECF gives Anunoby nine days between injury and competition, compared to the 2024 hamstring incident where he returned after four games missed and played visibly immobile. Mobility, not pain tolerance, is the threshold here. His description of the 2025 injury as "weird more than painful" and his successful return to full-contact drills are two separate signals pointing toward a player who will be available and functional, not one fighting through residual tightness.

The offensive production at stake is material. Anunoby is posting 21.4 points per playoff game on 61.9% true shooting and 53.8% from three—numbers that would rank among the top-tier wings in any postseason run. Defensively, he shadows opposing backcourts and wings with elite versatility. His availability at full intensity reshapes how the Knicks can space and defend in a potential Finals push.

For prop players, Anunoby's participation trajectory matters because it's now priced as uncertain when the underlying mechanism—time plus pain management—suggests near-certainty. Market oddsmakers typically apply a 20-30% availability discount to hamstring injuries within 10 days of event, a legacy conservatism born from repeat aggravations and mid-game departures. Anunoby's own medical team and his public statements both suggest the injury lacks the structural severity that triggered his 2024 absence. If he plays Tuesday, his offensive and assist-adjacent props (points, threes made, combined scoring lines) will be undervalued in early-week numbers because the market priced in a meaningful chance he sits out. The edge exists in the confidence gap between his recovery trajectory and the public probability of his availability. Once the Knicks confirm his status—likely by Monday—the numbers will shift materially.